Husband & Reznek's Imaging in Oncology
-10%
portes grátis
Husband & Reznek's Imaging in Oncology
Sahdev, Anju; Vinnicombe, Sarah J.
Taylor & Francis Ltd
11/2020
839
Dura
Inglês
9781138301238
15 a 20 dias
2960
Descrição não disponível.
PART I: PRIMARY TUMOUR EVALUATION AND STAGING. Tumours of the oral cavity and pharynx. Paranasal sinus and nasal cavity neoplasms. Laryngeal tumours. Thyroid cancer. Mediastinal tumours. Lung cancer. Pleural tumours. Breast cancer. Oesophageal cancer. Gastric cancer. Primary tumours of the liver and biliary tract. Pancreatic malignancy. Renal cancer. Primary adrenal malignancy. Primary retroperitoneal tumours. Bladder cancer. Prostate cancer. Testicular cancer. Ovarian cancer. Cervical and uterine tumours. Colorectal cancer. Primary bone tumours. Soft tissue sarcomas. Neuroendocrine tumours. PART II: HAEMATOLOGICAL MALIGNANCY AND IMMUNE RELATED MALIGNANCY. Lymphoma. Multiple myeloma. PART III: METASTASES. Brain metastases. Lymph node metastases. Lung and pleural metastases. Bone metastases. Liver and spleen metastases. Adrenal metastases. Peritoneal metastases. PART IV: DISEASE RESPONSE AND TREATMENT. Assessment of response to treatment. Tumour-specific disease response criteria. Immunotherapy response. PART V: EFFECTS ON NORMAL TISSUE AND COMPLICATIONS OF TREATMENTS. Oncological effects on the central nervous system. Effects of treatment on the thorax. Effects of treatment on the abdomen and pelvis. Effects of treatment on bone and bone marrow. PART VI: FUNCTIONAL AND MOLECULAR IMAGING. PET-CT: Principles and clinical applications. Functional imaging and emerging techniques in MRI. Functional imaging and emerging techniques in CT. Non-FDG radionuclide imaging and targeted therapies.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Progressive Disease;Lymph Node Metastases;GENERAL PRINCIPLES;T2W Mri;PRIMARY TUMOUR EVALUATION AND STAGING;Axial T2W Mri;HAEMATOLOGY MALIGNANCY;FDG Pet;EFFECTS OF TREATMENT ON NORMAL TISSUE;FDG Pet CT;FUNCTIONAL IMAGING;ADC Value;cancer radiology;Germ Cell Tumours;radiotherapy;GCT;RECIST Criterion;computed tomography;Malt Lymphoma;magnetic resonance imaging;CSI;laryngeal cancer treatment;RANO;bone involvement visualization;Modify RECIST Criterion;SWE;Papillary Thyroid Carcinoma;Hepatobiliary Phase;Adrenal Mass;Peritoneal Metastases;Malignant Pleural Mesothelioma;Malignant Peripheral Nerve Sheath Tumour;Soft Tissue Sarcomas;Non-target Lesion;Ground Glass Nodule;Liver Metastases
PART I: PRIMARY TUMOUR EVALUATION AND STAGING. Tumours of the oral cavity and pharynx. Paranasal sinus and nasal cavity neoplasms. Laryngeal tumours. Thyroid cancer. Mediastinal tumours. Lung cancer. Pleural tumours. Breast cancer. Oesophageal cancer. Gastric cancer. Primary tumours of the liver and biliary tract. Pancreatic malignancy. Renal cancer. Primary adrenal malignancy. Primary retroperitoneal tumours. Bladder cancer. Prostate cancer. Testicular cancer. Ovarian cancer. Cervical and uterine tumours. Colorectal cancer. Primary bone tumours. Soft tissue sarcomas. Neuroendocrine tumours. PART II: HAEMATOLOGICAL MALIGNANCY AND IMMUNE RELATED MALIGNANCY. Lymphoma. Multiple myeloma. PART III: METASTASES. Brain metastases. Lymph node metastases. Lung and pleural metastases. Bone metastases. Liver and spleen metastases. Adrenal metastases. Peritoneal metastases. PART IV: DISEASE RESPONSE AND TREATMENT. Assessment of response to treatment. Tumour-specific disease response criteria. Immunotherapy response. PART V: EFFECTS ON NORMAL TISSUE AND COMPLICATIONS OF TREATMENTS. Oncological effects on the central nervous system. Effects of treatment on the thorax. Effects of treatment on the abdomen and pelvis. Effects of treatment on bone and bone marrow. PART VI: FUNCTIONAL AND MOLECULAR IMAGING. PET-CT: Principles and clinical applications. Functional imaging and emerging techniques in MRI. Functional imaging and emerging techniques in CT. Non-FDG radionuclide imaging and targeted therapies.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Progressive Disease;Lymph Node Metastases;GENERAL PRINCIPLES;T2W Mri;PRIMARY TUMOUR EVALUATION AND STAGING;Axial T2W Mri;HAEMATOLOGY MALIGNANCY;FDG Pet;EFFECTS OF TREATMENT ON NORMAL TISSUE;FDG Pet CT;FUNCTIONAL IMAGING;ADC Value;cancer radiology;Germ Cell Tumours;radiotherapy;GCT;RECIST Criterion;computed tomography;Malt Lymphoma;magnetic resonance imaging;CSI;laryngeal cancer treatment;RANO;bone involvement visualization;Modify RECIST Criterion;SWE;Papillary Thyroid Carcinoma;Hepatobiliary Phase;Adrenal Mass;Peritoneal Metastases;Malignant Pleural Mesothelioma;Malignant Peripheral Nerve Sheath Tumour;Soft Tissue Sarcomas;Non-target Lesion;Ground Glass Nodule;Liver Metastases
